Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.

M. G. Kris, R. J. Gralla, M. T. Burke, L. D. Berkowitz, L. D. Marks, D. P. Kelsen, R. T. Heelan

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.'. Together they form a unique fingerprint.